Assessment of Adriamycin cardiotoxicity
β
H. E. Ulmer; R. Ludwig; H. Geiger
π
Article
π
1979
π
Springer
π
English
β 728 KB
In a prospective study, 44 children receiving Adriamycin (ADR) for various neoplastic diseases underwent serial estimations of the systolic time intervals (STI) for the noninvasive assessment of left ventricular myocardial performance. Five of the 44 children developed clinical signs of ADR-related